Personal Care
Baby And Mom Care
Bone And Joint
Cough And Cold
Hair Care
Sexual Wellness
Body Care
Skin Care
Miscellaneous
Health Conditions
Digestive Care
Pain Relief
Respiratory Care
Stomach Care
Healthcare Devices
BP Monitors
Nebulizers And Vaporizers
Supports And Braces
Vitamins And Supplements
Baby And Mom Care
Calcium And Minerals
Supplement Powder
Vitamin A To Z
Health Resources
All Salts
All Diseases
All Medicines
All Health Products
All Brands
Blogs

Meningococcal Vaccine (Group A, C, Y & W-135)

Uses

Meningococcal Vaccine (Group A, C, Y & W-135) is used to prevent meningococcal disease.

How it Works

How Meningococcal Vaccine (Group A, C, Y & W-135) works Meningococcal Vaccine (Group A, C, Y & W-135) is a vaccine that helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies, which are proteins that protect against future infections.

Side Effects

Common side effects of the Meningococcal Vaccine (Group A, C, Y & W-135) include headache, injection site pain, injection site redness, injection site induration (hardening of normally soft tissue or organ), irritability, sleepiness, general discomfort, muscle pain, and nausea.

Expert Advice

  • Meningococcal Vaccine (Group A, C, Y & W-135) is used to prevent meningococcal disease.
  • It is not recommended for use in infants and children under 9 months of age.
  • The vaccine is usually administered by injection into the muscle of the upper arm.
  • Your doctor will advise you if and when you should receive a booster dose.
  • Immunocompromised individuals or persons with functional or anatomic asplenia (including sickle cell disease) should receive the vaccine.
  • Individuals traveling to the US & Europe or attending Hajj (where meningococcal meningitis is more prevalent) are advised to get vaccinated with the Meningococcal Vaccine (Group A, C, Y & W-135).

Other Combinations

Diphtheria Toxoid + Meningococcal Vaccine (Group A

C

Y & W-135)

Related Medications

Molecule
Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135)

hero_image
Meningo A&C Injection
Sanofi India Ltd.
Vial of 1 ml
MRP

₹395

Sorry, the substitute medicine is Currently Unavailable
Molecule
Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135)

hero_image
Meningitis Act Injection
Sanofi India Ltd.
Vial of 1 ml
MRP

₹381.3

Sorry, the substitute medicine is Currently Unavailable
Molecule
Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135)

hero_image
Mencevax Acwy Vaccine Injection 1ml
Glaxo SmithKline Pharmaceuticals Ltd.
Vial of 1 ml
MRP

₹1,050

Sorry, the substitute medicine is Currently Unavailable
Molecule
Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135)

hero_image
Menomune Injection
Sanofi India Ltd.
Vial of 1 ml
MRP

₹518.4

Sorry, the substitute medicine is Currently Unavailable
Molecule
Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135)

hero_image
Menveo Vaccine 1s
GlaxoSmithKline Consumer Healthcare
Vial of 0
MRP

₹3,950

Sorry, the substitute medicine is Currently Unavailable
Molecule
Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135)

hero_image
Quadri Meningo Vaccine
Biomed Pharmaceuticals
Vial of 1 ml
MRP

₹1,150

Sorry, the substitute medicine is Currently Unavailable
Molecule
Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135)

hero_image
Mencevax Acwy Vaccine Injection 1s
Glaxo SmithKline Pharmaceuticals Ltd.
Vial of 1 unit
MRP

₹1,050

Sorry, the substitute medicine is Currently Unavailable
Molecule
Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135) 50mcg

hero_image
Quadrimeningo 50mcg Injection
Bio-Med Pvt. Ltd.
Vial of 1 ml
MRP

₹650

Sorry, the substitute medicine is Currently Unavailable

Frequently asked questions

The Meningococcal Vaccine (Group A, C, Y & W-135) is designed for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. It is approved for individuals aged 2 months to 55 years.
Individuals with a known allergy to any components of the Meningococcal Vaccine (Group A, C, Y & W-135) or similar vaccines should not receive it. Allergic reactions may include itchy rashes, shortness of breath, and facial or tongue swelling. Inform your doctor if you have a history of allergic reactions to medications.
The Meningococcal Vaccine (Group A, C, Y & W-135) should only be administered by a trained healthcare professional, typically via intramuscular injection in the upper arm or thigh for children. Follow your doctor's instructions for optimal results.
Yes, a booster dose may be given to individuals aged 15 to 55 years who are at continued risk for meningococcal disease, provided at least 4 years have passed since the last dose. Consult your doctor for guidance.
No, the Meningococcal Vaccine (Group A, C, Y & W-135) does not cause meningococcal disease. It stimulates your body to produce antibodies, enabling it to combat the infection if exposed in the future.
;

Flat ₹100 off on first app order   |    Use Code:  APP100   | 

Flat ₹100 off on first app order

USE CODE: APP100

PlatinumRx

Download Now

AppleIconPlayStoreIcon